| 臺大學術典藏 |
2020-07-31T11:24:35Z |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
HONG-YUAN HSU; MEI-HWEI CHANG; JIA-FENG WU; SHIANN-TARNG JOU; HUEY-LING CHEN; YEN-HSUAN NI; Hsu, Wei Yun; YUNG-LI YANG |
| 臺大學術典藏 |
2021-07-15T02:20:10Z |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
Hsu W.-Y.; Chang H.-H.; Lu M.-Y.; Yang Y.-L.; Jou S.-T.; HUEY-LING CHEN; Ni Y.-H.; Hsu H.-Y.; Chang M.-H.; Wu J.-F. |
| 臺大學術典藏 |
2020-12-16T07:21:43Z |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
Yang Y.-L.; Jou S.-T.; Chen H.-L.; Ni Y.-H.; Hsu H.-Y.; Chang M.-H.; Wu J.-F.; Hsu W.-Y.; Chang H.-H.; MENG-YAO LU |
| 臺大學術典藏 |
2020 |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
Chang M.-H.; Wu J.-F.; Hsu H.-Y.; Ni Y.-H.; Chen H.-L.; Jou S.-T.; Yang Y.-L.; Lu M.-Y.; HSIU-HAO CHANG; Hsu W.-Y. |
| 臺大學術典藏 |
2020-12-21T01:08:17Z |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
JIA-FENG WU; Chang M.-H.; Hsu H.-Y.; Hsu W.-Y.; Chang H.-H.; Lu M.-Y.; Yang Y.-L.; Jou S.-T.; Chen H.-L.; Ni Y.-H. |
| 臺大學術典藏 |
2020 |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
Chang H.-H.; Lu M.-Y.; Yang Y.-L.; Jou S.-T.; Chen H.-L.; YEN-HSUAN NI; Hsu H.-Y.; Chang M.-H.; Wu J.-F.; Hsu W.-Y.;Chang H.-H.;Lu M.-Y.;Yang Y.-L.;Jou S.-T.;Chen H.-L.;Yen-Hsuan Ni;Hsu H.-Y.;Chang M.-H.;Wu J.-F.; Hsu W.-Y. |
| 臺大學術典藏 |
2021-01-04T07:32:08Z |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
Hsu W.-Y.; Chang H.-H.; Lu M.-Y.; Yang Y.-L.; Jou S.-T.; Chen H.-L.; Ni Y.-H.; Hsu H.-Y.; MEI-HWEI CHANG; Wu J.-F. |
| 臺大學術典藏 |
2021-01-05T02:28:42Z |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
Chen H.-L.; SHIANN-TANG JOU; Yang Y.-L.; Lu M.-Y.; Chang H.-H.; Hsu W.-Y.; Ni Y.-H.; Hsu H.-Y.; Chang M.-H.; Wu J.-F. |
| 臺大學術典藏 |
2020 |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
Hsu W.-Y.; Chang H.-H.; Lu M.-Y.; YUNG-LI YANG; Jou S.-T.; Chen H.-L.; Ni Y.-H.; Hsu H.-Y.; Chang M.-H.; Wu J.-F. |
| 臺大學術典藏 |
2021-06-04T05:55:59Z |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
Hong-Yuan Hsu;Chang H.-H.;Lu M.-Y.;Yang Y.-L.;Jou S.-T.;Chen H.-L.;Ni Y.-H.;Hong-Yuan Hsu;Chang M.-H.;Wu J.-F.; HONG-YUAN HSU; Chang H.-H.; Lu M.-Y.; Yang Y.-L.; Jou S.-T.; Chen H.-L.; Ni Y.-H.; HONG-YUAN HSU; Chang M.-H.; Wu J.-F. |
| 臺大學術典藏 |
2022-02-22T06:20:36Z |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
Hsu, Wei-Yun; Chang, Hsiu-Hao; Lu, Meng-Yao; Yang, Yung-Li; Jou, Shiann-Tarng; Chen, Huey-Ling; Ni, Yen-Hsuan; HONG-YUAN HSU; Chang, Mei-Hwei; Wu, Jia-Feng |
| 南台科技大學 |
1998-03 |
Clinical Saccadic Stimulation Instrument
|
陳世中; Shih-Chung Chen; Ching-Hsing Luo |
| 中國醫藥大學 |
2011-10 |
Clinical Safety and Anticoagulation Efficacy of Low-Molecular-Weight in Chronic Hemodialysis Patients: A Single Medical Center Experience
|
莊峰榮(Feng-Rong Chuang);陳德全(Te-Chuan Chen);李志雄(Chih-Hsiung Lee);黃惠勇(Hwee-Yeong Huang);王怡寬(I-Kuan Wang);張學文(Hsueh-Wen Chang);莊博翔(Po-Hsiang Chuang);吳建興(Chien-Hsing Wu);楊智超(Chih-Chao Yang);蘇鈺壬 |
| 國立臺北護理健康大學 |
2020 |
Clinical Scenario Based Learning Appling to the Curriculum of Palliative Care in Long- Term Care: An Action Research and Effectiveness Evaluation
|
黃秀梨 |
| 亞洲大學 |
2015/07 |
CLINICAL SCIENCE
|
;Tang, 湯智昕 Chih-Hsin |
| 國立成功大學 |
2007-02 |
Clinical significance and distribution of putative virulence markers of 116 consecutive clinical Aeromonas isolates in southern Taiwan
|
Wu, Chi-Jung; Wu, Jiunn-Jong; Yan, Jing-Jou; Lee, Hsin-Chun; Lee, Nan-Yao; Chang, Chia-Ming; Shih, Hsin-I; Wu, Hsiu-Mei; Wang, Li-Rong; Ko, Wen-Chien |
| 國立臺灣大學 |
2014 |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su, Tung-Hung; Liu, Chun-Jen; Yang, Hung-Chih; Jeng, Yung-Ming; Cheng, Huei-Ru; Liu, Chen-Hua; Tseng, Tai-Chung; Ling, Thai-Yen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 林泰元; 高嘉宏; 鄭永銘; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 臺大學術典藏 |
2020-03-06T08:25:07Z |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su T.-H.; Liu C.-J.; Yang H.-C.; YUNG-MING JENG; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:39Z |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su T.-H.; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; CHEN-HUA LIU; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:11Z |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su T.-H.; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:46Z |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su T.-H; | Liu C.-J; | HUNG-CHIH YANG; | Jeng Y.-M; | Cheng H.-R; | Liu C.-H; | Tseng T.-C; | Ling T.-Y; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:11:43Z |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su T.-H.; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:31:43Z |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su T.-H.; CHUN-JEN LIU; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:41Z |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
TUNG-HUNG SU; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 國立成功大學 |
2004-06 |
Clinical significance and mechanism of gas formation of pyogenic liver abscess due to Klebsiella pneumoniae
|
Lee, Hsin-Ling; Lee, Hsin-Chun; Guo, How-Ran; Ko, Wen-Chien; Chen, Kuan-Wen |
| 國立成功大學 |
2003-11 |
Clinical significance and outcome of one or two rib lesions on bone scans in breast cancer patients without known metastases
|
Chen, Helen Hai-Wen; Su, W. C.; Guo, How-Ran; Lee, Bi-Fang; Su, Wei-Ren; Wu, Pei-Shan; Chiu, Nan-Tsing |
| 中國醫藥大學 |
2003 |
Clinical significance and prediction factors of gastric varices in patients with hepatocellular carcinoma
|
Yeh, JL; Peng, YC; Tung, CF; Yang, DY; Hu, WH; Chow, WK; Yeh, HZ; Chen, GH |
| 國立成功大學 |
2003-08 |
Clinical significance of allelotype profiling for urothelial carcinoma
|
Tzai, Tzong-Shin; Chen, Helen Hai-Wen; Chan, Shih-Huang; Ho, Chung-Liang; Tsai, Yuh-Shyan; Cheng, Hong-Lin; Dai, Yuan-Chang; Lin, Johnny Shinn-Nan; Yang, Wen-Horng |
| 國立臺灣大學 |
1989 |
Clinical Significance of Anatomy of Penile Deep Dorsal Vein
|
蔡崇璋; 陳世乾; Wang, Ching-Lun; 陳志榮; Hsieh, F. J.; 蔡崇璋; 陳世乾; Wang, Ching-Lun; Chen, Chi-Long; Hsieh, F. J. |
| 臺大學術典藏 |
2006-06 |
Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis.
|
Lin, FC;Chang, GD;Chern, MS;Chen, YC;Chang, SC; Lin, FC; Chang, GD; Chern, MS; Chen, YC; Chang, SC |
| 國立臺灣大學 |
2006-06 |
Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis.
|
Lin, FC; Chang, GD; Chern, MS; Chen, YC; Chang, SC |
| 國立臺灣大學 |
1985 |
Clinical Significance of Antin DNA Antibodies in ANA-Postive Systemic Lupus Erythematosus:Comparison of the Crithidia Luciliae Immunofluorescent Technique
|
吳英俊; 尹國霖; Wu, Ying-Chin; In, Kuo-Lin |
| 臺大學術典藏 |
2021-08-20T08:50:17Z |
Clinical significance of Blastocystis hominis: Experience from a medical center in northern Taiwan
|
HAN-YUEH KUO; Chiang D.-H.; Wang C.-C.; Chen T.-L.; Fung C.-P.; Lin C.-P.; Cho W.-L.; Liu C.-Y. |
| 慈濟大學 |
2012 |
Clinical Significance of Blood Pressure Ratios in Hypertensive Crisis in Children
|
Wu, Han-Ping;Yang, Wen-Chieh;Wu, Yung-Kang;Zhao, Lu-Lu;Chen, Chun-Yu;Fu, Yun-Ching |
| 中國醫藥大學 |
2012-09 |
Clinical significance of circulating IL-10 and fibronectin levels in hepatocellular carcinoma patients with HBV infection
|
(Chun-che Lin);殷梅津(YIN, MEI-CHIN)* |
| 國立臺灣大學 |
2015 |
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection
|
Cheng, Huei-Ru; Kao, Jia-Horng; Wu, Hui-Lin; Tseng, Tai-Chung; Liu, Chen-Hua; Yang, Hung-Chih; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 臺大學術典藏 |
2021-07-03T03:34:04Z |
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection
|
Cheng H.-R.; Kao J.-H.; Wu H.-L.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Su T.-H.; PEI-JER CHEN; Chen D.-S.; Liu C.-J. |
| 臺大學術典藏 |
2021-03-09T01:47:39Z |
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection
|
Cheng H.-R.; Kao J.-H.; Wu H.-L.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; TUNG-HUNG SU; Chen P.-J.; Chen D.-S.; Liu C.-J. |
| 臺大學術典藏 |
2021-05-24T07:20:37Z |
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection
|
Cheng H.-R.; Kao J.-H.; Wu H.-L.; Tseng T.-C.; CHEN-HUA LIU; Yang H.-C.; Su T.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J. |
| 臺大學術典藏 |
2021-07-12T02:44:43Z |
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection
|
Cheng H.-R; | Kao J.-H; | Wu H.-L; | Tseng T.-C; | Liu C.-H; | HUNG-CHIH YANG; | Su T.-H; | Chen P.-J; | Chen D.-S; | Liu C.-J. |
| 臺大學術典藏 |
2022-01-24T09:31:37Z |
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection
|
Cheng H.-R.; Kao J.-H.; Wu H.-L.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Su T.-H.; Chen P.-J.; Chen D.-S.; CHUN-JEN LIU |
| 臺大學術典藏 |
2021-09-04T06:11:30Z |
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection
|
Cheng H.-R.; JIA-HORNG KAO; Wu H.-L.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Su T.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J. |
| 臺大學術典藏 |
2018-09-10T15:24:59Z |
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection.
|
Huei-Ru Cheng, Jia-Horng Kao, Hui-Lin Wu, Tai-Chung Tseng, Chen-Hua Liu, Hung-Chih Yang, Tung-Hung Su, Pei-Jer Chen, Ding-Shinn Chen, Chun-Jen Liu; Cheng, Huei-Ru;Kao, Jia-Horng;Wu, Hui-Lin;Tseng, Tai-Chung;Liu, Chen-Hua;Yang, Hung-Chih;Su, Tung-Hung;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲; HUNG-CHIH YANG; Cheng, Huei-Ru; Kao, Jia-Horng; CHUN-JEN LIU; PEI-JER CHEN; Wu, Hui-Lin; CHEN-HUA LIU; Tseng, Tai-Chung; Liu, Chen-Hua; DING-SHINN CHEN; Yang, Hung-Chih; TUNG-HUNG SU; JIA-HORNG KAO; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen |
| 國立臺灣大學 |
2016 |
Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma
|
Chang, Ming-Chu; Chang, Yu-Ting; Chen, Jia-Yang; Jeng, Yung-Ming; Yang, Ching-Yao; Tien, Yu-Wen; Yang, Shih-Hung; Chen, Huai-Lu; Liang, Ting-Yuan; Wang, Chien-Fang; Lee, Eva Y. H. P.; Chang, Ying-Chih; Lee, Wen-Hwa; 鄭永銘; 章明珠; 田郁文; 楊卿堯; 張毓廷; 楊士弘 |
| 臺大學術典藏 |
2018-09-10T15:33:08Z |
Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma
|
Chang, Ming-Chu;Chang, Yu-Ting;Chen, Jia-Yang;Jeng, Yung-Ming;Yang, Ching-Yao;Tien, Yu-Wen;Yang, Shih-Hung;Chen, Huai-Lu;Liang, Ting-Yuan;Wang, Chien-Fang;Lee, Eva Y. H. P.;Chang, Ying-Chih;Lee, Wen-Hwa; Chang, M.-C. and Chang, Y.-T. and Chen, J.-Y. and Jeng, Y.-M. and Yang, C.-Y. and Tien, Y.-W. and Yang, S.-H. and Chen, H.-L. and Liang, T.-Y. and Wang, C.-F. and Lee, E.Y.H.P. and Chang, Y.-C. and Lee, W.-H.; 鄭永銘;章明珠;田郁文;楊卿堯;張毓廷;楊士弘; 鄭永銘;章明珠;田郁文;楊卿堯;張毓廷;楊士弘; YUNG-MING JENG; Chang, Ming-Chu; YU-TING CHANG; Chang, Yu-Ting; Chen, Jia-Yang; YU-WEN TIEN; CHING-YAO YANG; Jeng, Yung-Ming; Yang, Ching-Yao; Tien, Yu-Wen; Yang, Shih-Hung; Chen, Huai-Lu; Liang, Ting-Yuan; Wang, Chien-Fang; Lee, Eva Y. H. P.; Chang, Ying-Chih; Lee, Wen-Hwa |
| 臺大學術典藏 |
2020-02-20T06:53:08Z |
Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma
|
Chang M.-C.;Chang Y.-T.;Chen J.-Y.;Jeng Y.-M.;Yang C.-Y.;Yu-Wen Tien;Yang S.-H.;Chen H.-L.;Liang T.-Y.;Wang C.-F.;Lee E.Y.H.P.;Chang Y.-C.;Lee W.-H.; Chang M.-C.; Chang Y.-T.; Chen J.-Y.; Jeng Y.-M.; Yang C.-Y.; YU-WEN TIEN; Yang S.-H.; Chen H.-L.; Liang T.-Y.; Wang C.-F.; Lee E.Y.H.P.; Chang Y.-C.; Lee W.-H. |
| 臺大學術典藏 |
2020-02-20T02:56:56Z |
Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma
|
Chang M.-C.; Chang Y.-T.; Chen J.-Y.; Jeng Y.-M.; CHING-YAO YANG; Tien Y.-W.; Yang S.-H.; Chen H.-L.; Liang T.-Y.; Wang C.-F.; Lee E.Y.H.P.; Chang Y.-C.; Lee W.-H. |
| 臺大學術典藏 |
2020-03-06T08:24:55Z |
Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma
|
Chang M.-C.;Chang Y.-T.;Chen J.-Y.;Yung-Ming Jeng;Yang C.-Y.;Tien Y.-W.;Yang S.-H.;Chen H.-L.;Liang T.-Y.;Wang C.-F.;Lee E.Y.H.P.;Chang Y.-C.;Lee W.-H.; Chang M.-C.; Chang Y.-T.; Chen J.-Y.; YUNG-MING JENG; Yang C.-Y.; Tien Y.-W.; Yang S.-H.; Chen H.-L.; Liang T.-Y.; Wang C.-F.; Lee E.Y.H.P.; Chang Y.-C.; Lee W.-H. |
| 臺大學術典藏 |
2021-03-05T06:07:20Z |
Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma
|
MING-CHU CHANG; Chang Y.-T.; Chen J.-Y.; Jeng Y.-M.; Yang C.-Y.; Tien Y.-W.; Yang S.-H.; Chen H.-L.; Liang T.-Y.; Wang C.-F.; Lee E.Y.H.P.; Chang Y.-C.; Lee W.-H. |
| 臺大學術典藏 |
2021-08-10T03:53:05Z |
Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma
|
Chang M.-C.; Chang Y.-T.; Chen J.-Y.; Jeng Y.-M.; Yang C.-Y.; Tien Y.-W.; SHIH-HUNG YANG; Chen H.-L.; Liang T.-Y.; Wang C.-F.; Lee E.Y.H.P.; Chang Y.-C.; Lee W.-H. |
